Elanco Animal Health (NYSE:ELAN) reported Q4 EPS of $0.19, $0.06 better than the analyst estimate of $0.13. Revenue for the quarter came in at $988 million versus the consensus estimate of $982.82 million.
GUIDANCE:
Elanco Animal Health sees FY2023 EPS of $0.74-$0.83, versus the consensus of $0.99. Elanco Animal Health sees FY2023 revenue of $4.28-4.4 billion, versus the consensus of $4.39 billion.